126 related articles for article (PubMed ID: 26160020)
1. Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes.
Lee HY; Chang CY; Lai MJ; Chuang HY; Kuo CC; Chang CY; Chang JY; Liou JP
Bioorg Med Chem; 2015 Aug; 23(15):4230-4236. PubMed ID: 26160020
[TBL] [Abstract][Full Text] [Related]
2. Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones.
Chang CY; Chuang HY; Lee HY; Yeh TK; Kuo CC; Chang CY; Chang JY; Liou JP
Eur J Med Chem; 2014 Apr; 77():306-14. PubMed ID: 24657567
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
Wang F; Yang Z; Liu Y; Ma L; Wu Y; He L; Shao M; Yu K; Wu W; Pu Y; Nie C; Chen L
Bioorg Med Chem; 2015 Jul; 23(13):3337-50. PubMed ID: 25937236
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.
Romagnoli R; Baraldi PG; Salvador MK; Prencipe F; Bertolasi V; Cancellieri M; Brancale A; Hamel E; Castagliuolo I; Consolaro F; Porcù E; Basso G; Viola G
J Med Chem; 2014 Aug; 57(15):6795-808. PubMed ID: 25025853
[TBL] [Abstract][Full Text] [Related]
5. A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents.
Romagnoli R; Oliva P; Salvador MK; Manfredini S; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Rruga F; Mariotto E; Viola G; Bortolozzi R
Eur J Med Chem; 2021 Mar; 214():113229. PubMed ID: 33550186
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents.
Prasad B; Lakshma Nayak V; Srikanth PS; Baig MF; Subba Reddy NV; Babu KS; Kamal A
Bioorg Chem; 2019 Mar; 83():535-548. PubMed ID: 30472555
[TBL] [Abstract][Full Text] [Related]
7. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Part 2. The impact of bridging groups at position C-2.
Lee HY; Chang JY; Nien CY; Kuo CC; Shih KH; Wu CH; Chang CY; Lai WY; Liou JP
J Med Chem; 2011 Dec; 54(24):8517-25. PubMed ID: 22060033
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity.
Segaoula Z; Leclercq J; Verones V; Flouquet N; Lecoeur M; Ach L; Renault N; Barczyk A; Melnyk P; Berthelot P; Thuru X; Lebegue N
J Med Chem; 2016 Sep; 59(18):8422-40. PubMed ID: 27538123
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.
Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E
J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of N-methyl-5,6,7-trimethoxylindoles as novel antimitotic and vascular disrupting agents.
Zhao DG; Chen J; Du YR; Ma YY; Chen YX; Gao K; Hu BR
J Med Chem; 2013 Feb; 56(4):1467-77. PubMed ID: 23360369
[TBL] [Abstract][Full Text] [Related]
12. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Nov; 49(23):6656-9. PubMed ID: 17154496
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization.
Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cruz-Lopez O; Lopez Cara C; Tolomeo M; Grimaudo S; Di Cristina A; Pipitone MR; Balzarini J; Gambari R; Ilaria L; Saletti R; Brancale A; Hamel E
Bioorg Med Chem; 2008 Sep; 16(18):8419-26. PubMed ID: 18755591
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin.
Romagnoli R; Baraldi PG; Salvador MK; Prencipe F; Lopez-Cara C; Schiaffino Ortega S; Brancale A; Hamel E; Castagliuolo I; Mitola S; Ronca R; Bortolozzi R; Porcù E; Basso G; Viola G
J Med Chem; 2015 Apr; 58(7):3209-22. PubMed ID: 25785605
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of aryloxazole derivatives as antimitotic and vascular-disrupting agents for cancer therapy.
Choi MJ; No ES; Thorat DA; Jang JW; Yang H; Lee J; Choo H; Kim SJ; Lee CS; Ko SY; Lee J; Nam G; Pae AN
J Med Chem; 2013 Nov; 56(22):9008-18. PubMed ID: 24160376
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents.
Tian C; Chen X; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2019 Dec; 183():111679. PubMed ID: 31541870
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents.
Lai MJ; Kuo CC; Yeh TK; Hsieh HP; Chen LT; Pan WY; Hsu KY; Chang JY; Liou JP
ChemMedChem; 2009 Apr; 4(4):588-93. PubMed ID: 19266513
[TBL] [Abstract][Full Text] [Related]
18. Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy.
Arnst KE; Wang Y; Lei ZN; Hwang DJ; Kumar G; Ma D; Parke DN; Chen Q; Yang J; White SW; Seagroves TN; Chen ZS; Miller DD; Li W
Mol Pharmacol; 2019 Jul; 96(1):73-89. PubMed ID: 31043459
[TBL] [Abstract][Full Text] [Related]
19. Substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationships.
Fortin S; Wei L; Moreau E; Lacroix J; Côté MF; Petitclerc E; Kotra LP; Gaudreault RC
Eur J Med Chem; 2011 Nov; 46(11):5327-42. PubMed ID: 21920638
[TBL] [Abstract][Full Text] [Related]
20. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
Li PK; Pandit B; Sackett DL; Hu Z; Zink J; Zhi J; Freeman D; Robey RW; Werbovetz K; Lewis A; Li C
Mol Cancer Ther; 2006 Feb; 5(2):450-6. PubMed ID: 16505120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
